R&D
We start with the material, not a finished product.
R&D
We start
with the material
ROSE LAB does not buy in someone else's material and blend it. We find and design the material ourselves. That is why, in 2016 — the year the company was founded — the research institute came first.
Fields
Fields of research
Four things have to happen before a material becomes a product. Skip any one of them and the material stays a material.
Materials research
We search for and design the polymer materials used in tissue restoration and aesthetic medicine. Every product the company makes begins at this stage, in the corporate research institute established in 2016.
Formulation
A good material is not yet a good product. What follows is the work of finding a form that holds it stably, handles easily and does not change in use — the distance between a substance in the laboratory and a product in the hand is closed here.
Safety verification
For anything used on the body, safety comes before efficacy. Verification runs with testing and clinical research institutions in Korea and abroad, and a material that fails here does not move on.
Regulatory design
A material that cannot clear approval never becomes a product. So regulatory requirements are not fitted at the end but built into the design from the start, with domestic licensing and overseas registration prepared to the same standard.
Programmes
National R&D programmes
National R&D programmes are not granted on application; they are awarded on review. ROSE LAB has been selected nine times since its founding year.
MSS POST TIPS programme
MSS SME Technology Innovation programme (market expansion)
KISTA IP-R&D strategy support programme
MOTIE Scale-up Technology Commercialisation, R&D stage
MOTIE Scale-up Technology Commercialisation programme
KISED Start-up Leap Package
MSS SME Technology Development programme (TIPS)
MSS Industry-Academic Leap Support
SMBA Industry-Academic First Step
IP
We keep our research as rights
Research results are not left as documents alone. In 2023 the company was selected for the KISTA IP-R&D strategy support programme and restructured its patent portfolio.
4 registered · 6 filed
Filed in the US, Europe, China and more
Filed and registered in Korea and abroad
We are looking for partners
We welcome distribution, partnership and product enquiries.